Slider

Astellas Announces the Opening of Its New Gene Therapy Manufacturing Facility in North Carolina
Astellas Announces the Opening of Its New Gene Therapy Manufacturing Facility in North Carolina
Astellas Pharma Inc has announced the opening of a new late stage clinical and commercial manufacturing facility in Sanford, North Carolina, US. The facility will allow the company to expand its resources and team to establish a robust, global supply chain and expand its therapeutic and geographic scope. Article Summary The new 135,000 square-foot state-of-the-art...
by admin0
Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World
Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World
The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs has accelerated the plans to build capacity to manufacture more than 10,000 patient therapies in direct response to the critical shortage of cell therapy supply, which will help patients win their courageous battles against cancer. Article Summary Planning has begun on a massive...
by admin0
Prescient Therapeutics Unveils its New Cell Therapy Platform – CellPryme-M
Prescient Therapeutics Unveils its New Cell Therapy Platform – CellPryme-M
A clinical-stage oncology company Prescient Therapeutics (PTX) has launched its second cell therapy platform, CellPryme-M, which produces superior cells with greater cancer killing activity. This platform opens commercial opportunities for the company to incorporate it into third-party manufacturing processes. Article Summary PTX has developed this new platform technology in association with its research partner, Peter...
by admin0
Tessa Therapeutics Closes a US$126 million Series A financing Round
Tessa Therapeutics Closes a US$126 million Series A financing Round
Article Summary Tessa Therapeutics Ltd has announced the close of a US$126 million Series A financing round. The funding was led by Polaris Partners and existing investors, including Temasek, EDBI, Heliconia Capital and Heritas Capital. In conjunction with the financing, Amy Schulman and Darren Carroll, Managing Partners at Polaris Partners, have joined Tessa’s Board of...
by admin0
The European Investment Bank (EIB) has provided €75 million to the Institut Pasteur de Dakar for the construction of a new vaccine manufacturing facility.
The European Investment Bank (EIB) has provided €75 million to the Institut Pasteur de Dakar for the construction of a new vaccine manufacturing facility.
Excerpt Large-scale funding for the Institut Pasteur de Dakar’s new vaccine manufacturing facility, a leader in the area in Africa. The facility, which would produce up to 300 million doses per year against COVID-19 and other endemic diseases, is projected to considerably reduce Africa’s reliance on imported vaccines and support equal access to medicines. This...
by admin0
GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc.
GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc.
Excerpt GSK will pay $2.1 billion up front and up to $1.2 billion in development milestone payments. The proposed acquisition will give the company access to a next-generation 24-valent pneumococcal vaccine candidate in phase II development as well as MAPSTM technology, which is extremely innovative. Encourages the development of a diverse portfolio of novel vaccines...
by admin0